Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial by Czepielewski, M.A., Garret, Q., Vencio, S.A.C., Rassi, N., Faria, M.S., Senn, C.C.P., Bronstein, M.D., Cerqueira, M.J.A.G., Neves, A.C.L., Spinola-Castro, A.M., Cunha, M.P.R., Leite, N.R., Wassermann, G.E., Alegria, M.C., Toffoletto, O., Afiune, J., Baradelli, R., Rodrigues, D.G., Scharf, M.

Get full text

Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A ran... by Czepielewski, M.A., Garret, Q., Vencio, S.A.C., Rassi, N., Felicio, J.S., Faria, M.S., Senn, C.C.P., Bronstein, M.D., Cerqueira, M.J.A.G., Neves, A.C.L., Sgarbi, J.A., Spinola-Castro, A.M., Cunha, M.P.R., Bandeira, F., Toffoletto, O., Afiune, J., Baradelli, R., Rodrigues, D.G., Scharf, M.

Get full text